Phelan-McDermid综合征咨询的共识建议: 特别注意复发风险和环22号染色体

2023-04-27 欧洲Phelan-Mcdermid综合征联盟(the European Phelan-McDermid syndrome consortium) Eur J Med Genet . 2023 Apr 27 发表于广东省

本文着重于对Phelan-Mcdermid综合征(PMS)的遗传咨询,PMS是一种罕见的神经发育障碍。欧洲PMS综合征联盟发布此篇共识作为Phelan-Mcdermid综合征的遗传咨询指南

中文标题:

Phelan-McDermid综合征咨询的共识建议: 特别注意复发风险和环22号染色体

英文标题:

Consensus recommendations on counselling in Phelan-McDermid syndrome, with special attention to recurrence risk and to ring chromosome 22

发布日期:

2023-04-27

简要介绍:

本文着重于对Phelan-Mcdermid综合征(PMS)的遗传咨询,PMS是一种罕见的神经发育障碍,由SHANK3基因22q13.3缺失或致病变异引起。这是欧洲PMS综合征联盟作为共识指南撰写的一系列论文之一。

相关资料下载:
[AttachmentFileName(sort=1, fileName=1-s2.0-S1769721223000794-main.pdf)] GetToolGuiderByIdResponse(projectId=1, id=69b331c003120e25, title=Phelan-McDermid综合征咨询的共识建议: 特别注意复发风险和环22号染色体, enTitle=Consensus recommendations on counselling in Phelan-McDermid syndrome, with special attention to recurrence risk and to ring chromosome 22, guiderFrom=Eur J Med Genet . 2023 Apr 27, authorId=0, author=, summary=本文着重于对Phelan-Mcdermid综合征(PMS)的遗传咨询,PMS是一种罕见的神经发育障碍。欧洲PMS综合征联盟发布此篇共识作为Phelan-Mcdermid综合征的遗传咨询指南, cover=https://img.medsci.cn/20221109/1668019396776_4754896.png, journalId=0, articlesId=null, associationId=4588, associationName=欧洲Phelan-Mcdermid综合征联盟(the European Phelan-McDermid syndrome consortium), associationIntro=欧洲Phelan-Mcdermid综合征联盟the European Phelan-McDermid syndrome consortium, copyright=0, guiderPublishedTime=Thu Apr 27 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<p>本文着重于对Phelan-Mcdermid综合征(PMS)的遗传咨询,PMS是一种罕见的神经发育障碍,由SHANK3基因22q13.3缺失或致病变异引起。这是欧洲PMS综合征联盟作为共识指南撰写的一系列论文之一。</p>, tagList=[TagDto(tagId=10637, tagName=罕见病), TagDto(tagId=474719, tagName=phelan-mcdermid综合征), TagDto(tagId=474987, tagName=PMS)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=304, categoryName=罕见病, tenant=100), CategoryDto(categoryId=21072, categoryName=罕见病网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=474719, articleKeyword=phelan-mcdermid综合征, articleKeywordNum=6, guiderKeywordId=10637, guiderKeyword=罕见病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1864, appHits=3, showAppHits=0, pcHits=131, showPcHits=1861, likes=0, shares=1, comments=3, approvalStatus=1, publishedTime=Sun Apr 30 12:43:49 CST 2023, publishedTimeString=2023-04-27, pcVisible=1, appVisible=1, editorId=0, editor=lixiang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=lixiang, createdTime=Sun Apr 30 12:52:07 CST 2023, updatedBy=4754896, updatedName=侠胆医心, updatedTime=Fri Jan 05 18:03:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=广东省, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=1-s2.0-S1769721223000794-main.pdf)])
1-s2.0-S1769721223000794-main.pdf
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2129641, encodeId=cc0e2129641da, content=<a href='/topic/show?id=bbb8106088cf' target=_blank style='color:#2F92EE;'>#Phelan-McDermid综合征#</a>咨询的共识建议: 特别注意复发风险和环22号染色体<a href='/topic/show?id=855910608965' target=_blank style='color:#2F92EE;'>#SHANK3基因#</a><a href='/topic/show?id=5ecce424448' target=_blank style='color:#2F92EE;'>#神经发育障碍#</a><a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a> Phelan-McDermid综合征(Phelan-McDermid syndrome,PMS)(MIM 6062322)是由22号染色体长臂末端缺失引起的较为罕见的<a href='/topic/show?id=fd309513314' target=_blank style='color:#2F92EE;'>#遗传性疾病#</a>,男女发病率无明显差异。一项对11000多例发育障碍患者亚端粒重排的研究,发现22q13是仅次于1p36的第二常见亚端粒重排区,会导致显著的染色体疾病,但由于临床上缺乏对该病的认识及相关检测技术的限制,其具体的患病率仍难以确定。有研究指出,80%~85%的PMS是"新发事件"。在新发患者中,发生缺失的染色体70%为父源性,该病的具体发病机制目前仍不清楚。PMS临床表现复杂多样,主要包括<a href='/topic/show?id=2c8510609267' target=_blank style='color:#2F92EE;'>#全面发育落后#</a>、<a href='/topic/show?id=7e2a6003078' target=_blank style='color:#2F92EE;'>#智力障碍#</a>、<a href='/topic/show?id=6d1710609368' target=_blank style='color:#2F92EE;'>#肌张力降低#</a>、<a href='/topic/show?id=7704918133a' target=_blank style='color:#2F92EE;'>#语言发育迟缓#</a>、轻度畸形及<a href='/topic/show?id=4266863e7bd' target=_blank style='color:#2F92EE;'>#自闭症#</a>(autism spectrum disorde,ASD)等,由于其缺乏特异性的临床表现,经常被误诊。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=106088, encryptionId=bbb8106088cf, topicName=Phelan-McDermid综合征), TopicDto(id=106089, encryptionId=855910608965, topicName=SHANK3基因), TopicDto(id=74244, encryptionId=5ecce424448, topicName=神经发育障碍), TopicDto(id=79556, encryptionId=5a8be955621, topicName=罕见病), TopicDto(id=95133, encryptionId=fd309513314, topicName=遗传性疾病), TopicDto(id=106092, encryptionId=2c8510609267, topicName=全面发育落后), TopicDto(id=60030, encryptionId=7e2a6003078, topicName=智力障碍), TopicDto(id=106093, encryptionId=6d1710609368, topicName=肌张力降低), TopicDto(id=91813, encryptionId=7704918133a, topicName=语言发育迟缓), TopicDto(id=86377, encryptionId=4266863e7bd, topicName=自闭症)], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20230502/5fb6f3e6d38c4f8c9a439762d10d0d44.webp, type=image, width=0, height=0)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Tue May 02 02:30:55 CST 2023, time=2023-05-02, status=1, ipAttribution=上海)]

拓展阅读

罕见疾病药物临床研发技术指导原则(征求意见稿)

国家药品监督管理局药品审评中心(CDE) · 2021-10-07

FDA罕见病:早期药物开发和 IND 前会议的作用

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2021-10-01

FDA工业指南:罕见病:行业药物开发中的常见问题

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2021-10-01

FDA工业指南:罕见病:自然史研究用于药物开发

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2021-10-01